DYLAN BAILEY: Open Payments
NPI 1669900643 · WILLIAMSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$936 in 30 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $936
Food & beverage: $936
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $225 |
| Ipsen Biopharmaceuticals, Inc | 4 | $177 |
| Regeneron Healthcare Solutions, Inc. | 2 | $153 |
| Ardelyx, Inc. | 5 | $105 |
| ABBVIE INC. | 4 | $86 |
| Lilly USA, LLC | 3 | $71 |
| Celltrion USA Inc. | 3 | $53 |
| Novo Nordisk Inc | 2 | $47 |
| Gilead Sciences, Inc. | 1 | $18 |
Products named: TREMFYA, IQIRVO, DUPIXENT, IBSRELA, OMVOH, VEGZELMA, Wegovy, SKYRIZI.
Industry payments across VA — which companies pay providers there.
